Cannabis Beverages: Market Growth, Products, and Regulatory Landscape

Executive Summary

Cannabis-infused beverages represent the fastest-growing segment of the legal marijuana market, projected to reach $2.8 billion in U.S. sales by 2027. These products deliver THC, CBD, and other cannabinoids through water-soluble formulations that offer faster onset times than traditional edibles—typically 15-30 minutes versus 60-90 minutes for baked goods. The category spans THC-dominant recreational drinks, CBD wellness beverages, and hemp-derived products sold outside state-licensed dispensaries. Major alcohol companies including Constellation Brands, Molson Coors, and Anheuser-Busch InBev have invested hundreds of millions in cannabis beverage partnerships since 2018, anticipating substitution effects as consumers seek alternatives to alcohol. Regulatory complexity remains the sector's defining challenge: beverages must comply with state-specific THC limits (typically 5-10mg per serving), child-resistant packaging requirements, and federal restrictions that prohibit interstate commerce. Recent developments include Splash Beverage Group's May 2026 appointment of Brady Cobb to lead its pivot from alcohol to cannabinoid beverages, signaling continued mainstream interest despite ongoing federal prohibition under the Controlled Substances Act.

Why Cannabis Beverages Matter

Cannabis beverages bridge the gap between traditional alcohol consumption patterns and legal marijuana markets, creating a $500 million annual category that grew 40% year-over-year in 2025. The segment matters to multiple stakeholder groups for distinct reasons. Consumers gain precise dosing control and faster onset compared to edibles, with single-serve formats mimicking beer and cocktail social rituals. Medical patients benefit from smoke-free delivery methods that avoid respiratory irritation while maintaining bioavailability rates approaching 80% with nanoemulsion technology—far exceeding the 10-20% absorption of traditional edibles. Multi-state operators view beverages as margin expansion opportunities. Wholesale prices for THC beverages average $4-7 per unit compared to $2-4 for edibles, while retail prices reach $8-15 per can. California dispensaries reported beverage sales comprising 3-5% of total revenue in 2025, up from less than 1% in 2020. Operators including Curaleaf, Cresco Labs, and Green Thumb Industries have launched proprietary beverage lines or partnered with specialized manufacturers. Traditional alcohol companies face existential questions about cannabis substitution. Nielsen survey data from 2024 found 27% of legal-state cannabis consumers reduced alcohol consumption after trying THC beverages. Constellation Brands invested $4 billion in Canadian producer Canopy Growth specifically to develop cannabis drinks for eventual U.S. market entry. Molson Coors formed Truss Beverage Company in partnership with HEXO Corp, while Lagunitas Brewing launched Hi-Fi Hops, a THC-infused sparkling water, in California. State tax authorities recognize beverages as high-compliance revenue generators. Colorado collected $45 million in excise taxes from cannabis beverages in 2025, with tracking systems showing 99.2% compliance rates—higher than flower or concentrate categories. The single-serve format and established distribution models from alcohol reduce diversion risks.

Background and History

Cannabis beverages evolved from crude THC-infused teas in 1960s counterculture to sophisticated nanoemulsion products backed by Fortune 500 alcohol companies.

Early Experimentation (1960s-1990s)

The first cannabis beverages were homemade teas and tinctures prepared by steeping marijuana flower in hot water or alcohol. These preparations delivered inconsistent doses and poor bioavailability due to THC's lipophilic nature—cannabinoids dissolve in fats, not water. Bhang, a traditional Indian cannabis drink mixed with milk and spices, represented one of the few culturally established beverage formats. Underground cannabis cookbooks from the 1970s included recipes for "pot tea" and cannabis-infused hot chocolate, but commercial products remained nonexistent under federal prohibition.

Medical Market Emergence (1996-2010)

California's Compassionate Use Act of 1996 created the first legal framework for cannabis products, but early medical dispensaries focused on flower and basic edibles. The first commercial cannabis beverage appeared around 2003 when California manufacturers began producing THC-infused lemonades and iced teas using glycerin-based tinctures. These products suffered from separation issues—cannabinoids would settle at the bottom of bottles—and unpredictable effects. Dixie Elixirs, founded in Colorado in 2009, became one of the first companies to focus exclusively on cannabis beverages, developing a 12-ounce soda format containing 75mg THC.

Colorado Legalization and Dosing Reforms (2012-2016)

Colorado's Amendment 64 in 2012 and subsequent retail sales beginning January 2014 transformed cannabis beverages from niche medical products to recreational consumer goods. Early recreational beverages contained 100mg or more THC per bottle, leading to overconsumption incidents. The Colorado Department of Revenue responded with emergency rules in 2015 requiring single-serve containers not exceed 10mg THC and multi-serve products include 10mg serving demarcations. These standards became the national template. Washington state's I-502 implementation in 2014 included similar 10mg serving limits from launch. Manufacturers began investing in emulsion technology to improve cannabinoid stability in water-based products. Keef Brands, founded in 2014, pioneered the use of nanoemulsion—reducing cannabinoid particles to 10-100 nanometers—which improved onset times from 60-90 minutes to 15-30 minutes.

California Adult-Use and Alcohol Industry Entry (2016-2020)

California's Proposition 64 passage in November 2016 created the world's largest legal cannabis market, attracting mainstream beverage industry attention. Constellation Brands announced its initial $191 million investment in Canopy Growth in October 2017, followed by an additional $4 billion investment in August 2018—the largest cannabis industry transaction to date. The company stated its intent to develop cannabis-infused beverages for U.S. markets pending federal legalization. Molson Coors and HEXO Corp formed Truss Beverage Company in August 2018, launching products in Canada following October 2018 federal legalization. Lagunitas Brewing, owned by Heineken, introduced Hi-Fi Hops in California dispensaries in 2019—a 10mg THC sparkling water with cannabis terpenes. Anheuser-Busch InBev partnered with Tilray in December 2018 to research non-alcoholic cannabis beverages. California's regulated adult-use market launched January 2018 with strict manufacturing requirements under the Medicinal and Adult-Use Cannabis Regulation and Safety Act. The Bureau of Cannabis Control required beverage manufacturers obtain separate licenses, implement batch testing for potency and contaminants, and use child-resistant packaging. Initial products included Keef Brands' sodas, CannaCraft's Care By Design CBD beverages, and Dixie Brands' elixirs.

Nanoemulsion Technology Advances (2018-2022)

The period from 2018-2022 saw rapid improvements in water-soluble cannabinoid formulations. Traditional emulsions used surfactants to suspend cannabinoid particles at 1,000-5,000 nanometers, resulting in cloudy appearance and 45-60 minute onset times. Nanoemulsion technology reduced particle size to 10-100 nanometers, creating clear beverages with onset times as fast as 10-15 minutes and bioavailability rates of 70-90%. Vertosa, founded in 2018, became a leading white-label nanoemulsion supplier to cannabis beverage brands. The company's technology used high-pressure homogenization and food-grade surfactants to create stable emulsions with shelf lives exceeding 12 months. Ceria Brewing, launched by former Blue Moon founder Keith Villa in 2020, used proprietary emulsion technology to create THC-infused craft beers with traditional beer flavor profiles.

Federal Hemp Legalization and CBD Beverages (2018-Present)

The Agriculture Improvement Act of 2018 removed hemp (cannabis with less than 0.3% delta-9 THC) from Schedule I of the Controlled Substances Act, creating a legal pathway for CBD beverages sold outside state-licensed cannabis systems. Major beverage companies launched CBD products: Coca-Cola explored CBD drinks but did not launch products, while Molson Coors introduced Truss CBD beverages in Colorado in 2020. The Food and Drug Administration issued warning letters to CBD beverage manufacturers throughout 2019-2020, stating that adding CBD to food and beverages violated the Federal Food, Drug, and Cosmetic Act because CBD was an active ingredient in the FDA-approved drug Epidiolex. Despite regulatory uncertainty, CBD beverage sales reached $260 million in 2021 according to Brightfield Group data. Products included Recess (CBD-infused sparkling water), Weller (CBD coffee), and numerous regional brands sold in conventional retail channels.

Market Maturation and MSO Entry (2022-2026)

Multi-state operators increasingly viewed beverages as strategic priorities after 2022. Cresco Labs launched FloraCal Farms beverages in California in 2023. Curaleaf partnered with Select for co-branded THC seltzers in multiple states. Green Thumb Industries expanded its Beboe brand into beverages. Verano Holdings launched Encore edibles and beverages line in 2024. Technology improvements continued with faster onset formulations. Cann Social Tonics, founded in 2019 and backed by celebrities including Gwyneth Paltrow, achieved 10-15 minute onset times and positioned products as "social" alternatives to alcohol. The company raised $27 million in Series A funding in 2022 and expanded to California, Nevada, and Illinois. Splash Beverage Group's May 2026 appointment of Brady Cobb, CEO of Florida-based Sunburn Cannabis, to lead its cannabinoid beverage strategy represented continued mainstream interest. The NYSE-listed company announced plans to transition from alcohol-focused operations to cannabinoid and regulated wellness beverages, citing higher growth projections in cannabis versus declining alcohol consumption among younger demographics.

Key Players

Canopy Growth and Constellation Brands

Canopy Growth Corporation operates as the world's largest cannabis company by market capitalization, with Constellation Brands holding a 38% equity stake following $4 billion in investments. The partnership focuses on developing cannabis beverages for North American markets. Canopy's Tweed and Houseplant brands offer THC beverages in Canada, while the company awaits U.S. federal reform to launch products domestically. Constellation's beverage distribution infrastructure—including relationships with retailers, distributors, and logistics providers—positions the partnership to rapidly scale if federal prohibition ends.

Molson Coors and Truss Beverage Company

Molson Coors Beverage Company formed Truss Beverage Company as a joint venture with Canadian producer HEXO Corp in 2018. Truss launched cannabis beverages in Canada in 2020, including Veryvell CBD drinks, Little Victory non-alcoholic cannabis drinks, and Mollo THC beverages. The company operates a 58,000-square-foot manufacturing facility in Ontario. Molson Coors views cannabis beverages as a hedge against declining beer consumption, particularly among consumers aged 21-35 who show higher cannabis adoption rates.

Cann Social Tonics

Cann manufactures low-dose THC beverages (2mg THC, 4mg CBD per can) positioned as social drinking alternatives. Founded in 2019 by Jake Bullock and Luke Anderson, the company operates in California, Nevada, and Illinois. Cann raised $27 million in Series A funding in 2022 led by Imaginary Ventures, with participation from celebrities including Gwyneth Paltrow, Rosario Dawson, and Tove Lo. The brand emphasizes "microdosing" and social consumption occasions, with marketing focused on replacing the first or second alcoholic drink at social gatherings.

Keef Brands

Keef Brands, founded in 2014 in Colorado, operates as one of the oldest cannabis beverage manufacturers. The company produces sodas, mocktails, and energy drinks with THC doses ranging from 10mg to 100mg per bottle. Keef pioneered nanoemulsion technology for faster onset and operates manufacturing facilities in Colorado, California, Nevada, Michigan, and Oklahoma. The company reported $42 million in revenue in 2024 and distributes through more than 1,200 dispensaries.

Vertosa

Vertosa provides white-label nanoemulsion technology to cannabis beverage brands, operating as a business-to-business supplier rather than consumer brand. Founded in 2018, the company's emulsion platform enables onset times of 10-20 minutes and bioavailability rates exceeding 80%. Vertosa partners with more than 50 cannabis brands across 15 states, including partnerships with Wana Brands, 1906, and Kiva Confections. The company raised $25 million in Series B funding in 2023.

Lagunitas and Hi-Fi Hops

Lagunitas Brewing Company, owned by Heineken International, launched Hi-Fi Hops in California in 2019 as a THC-infused sparkling water containing 10mg THC and cannabis terpenes. The product contains no alcohol and uses Lagunitas' brewing expertise to create hop-forward flavor profiles. Hi-Fi Hops expanded to dispensaries throughout California and represents one of the few cannabis products from a major international alcohol company available in U.S. markets.

Splash Beverage Group and Brady Cobb

Splash Beverage Group (NYSE: SBEV) announced in May 2026 the appointment of Brady Cobb to lead its strategic pivot from alcohol to cannabinoid beverages. Cobb serves as CEO of Sunburn Cannabis, a Florida-based multi-state operator with operations in Florida, Massachusetts, and Pennsylvania. The appointment signals Splash Beverage's intent to leverage Cobb's cannabis industry experience and regulatory expertise to enter the cannabinoid beverage market. The company previously focused on alcohol brands including TapouT and Salt Tequila.

Food and Drug Administration

The FDA regulates cannabis beverages through multiple statutory authorities. THC beverages remain prohibited under the Controlled Substances Act and federal Food, Drug, and Cosmetic Act. CBD beverages exist in regulatory limbo—the FDA maintains that adding CBD to food and beverages violates federal law because CBD is an active ingredient in Epidiolex, an FDA-approved drug for epilepsy. The agency issued warning letters to CBD beverage manufacturers in 2019-2020 but has not taken enforcement actions against major brands. The FDA has not established a regulatory pathway for cannabis beverages pending congressional action.

State Regulatory Agencies

State cannabis control boards establish manufacturing standards, testing requirements, and packaging rules for THC beverages. California's Department of Cannabis Control requires beverage manufacturers obtain Type N licenses, implement standard operating procedures, and test every batch for potency, pesticides, heavy metals, and microbial contaminants. Colorado's Marijuana Enforcement Division pioneered the 10mg THC per serving standard adopted by most legal states. Massachusetts Cannabis Control Commission requires opaque, child-resistant packaging and prohibits marketing that appeals to minors.

Legal and Regulatory Framework

Cannabis beverages operate under a complex patchwork of state regulations while remaining federally prohibited under 21 U.S.C. § 812, creating compliance challenges and interstate commerce barriers. The Controlled Substances Act classifies marijuana as a Schedule I substance, making THC beverages illegal under federal law regardless of state legalization. This prohibition prevents interstate commerce—manufacturers cannot ship products across state lines even between two legal states. Each state market requires separate manufacturing facilities, licenses, and supply chains. State regulations typically derive authority from voter-approved initiatives or legislative acts. California's Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) established the regulatory framework for cannabis beverages. Colorado's Amendment 64 and subsequent legislation created the Colorado Marijuana Code. These state frameworks share common elements but differ in crucial details. Dosing limits represent the most universal standard. Most states cap single-serve beverages at 10mg THC, following Colorado's 2015 emergency rules. Multi-serve containers typically cannot exceed 100mg total THC and must include clear 10mg serving demarcations. California, Colorado, Washington, Oregon, Nevada, Michigan, Illinois, Massachusetts, and Arizona all use the 10mg single-serve standard. Some states impose lower limits: Vermont caps beverages at 5mg per serving. Testing requirements mandate laboratory analysis of every production batch. California requires testing for potency (THC and CBD percentages), pesticides (66 compounds), heavy metals (four elements including lead and arsenic), microbial contaminants (E. coli, salmonella, aspergillus), and mycotoxins. Batches failing any test cannot be sold and must be destroyed. Testing costs range from $400-800 per batch, adding significant expense to small production runs. Packaging regulations aim to prevent youth access and accidental consumption. Child-resistant packaging meeting 16 C.F.R. § 1700.20 standards is mandatory in all legal states. Opaque containers preventing visual inspection of contents are required in most jurisdictions. Labels must include THC content in milligrams, warning statements, universal cannabis symbol, batch number, and manufacturing date. Marketing restrictions prohibit cartoon characters, bright colors appealing to children, and health claims. Manufacturing licenses impose facility and process requirements. California's Type N license for non-infused pre-packaged products costs $1,000-96,000 annually based on gross revenue. Facilities must pass inspections verifying proper ventilation, sanitation, security systems, and inventory tracking. Standard operating procedures must document every production step. Many states require manufacturers also hold distributor licenses to transport products to dispensaries. The Federal Food, Drug, and Cosmetic Act creates additional complexity for CBD beverages. Section 331(ll) prohibits introducing into interstate commerce any food containing CBD because CBD is an active ingredient in FDA-approved drug Epidiolex. The FDA has not established a legal pathway for CBD beverages despite the 2018 Farm Bill legalizing hemp. This regulatory gap allows CBD beverage sales to continue in conventional retail channels with minimal enforcement, but manufacturers face legal uncertainty. Tax structures vary significantly by state. California imposes a 15% excise tax on retail sales plus state and local sales taxes totaling 7-10%. Illinois charges 10% cannabis excise tax on products under 35% THC. Colorado levies a 15% retail marijuana sales tax plus 15% excise tax on wholesale transfers. These taxes apply to beverages identically to other cannabis products, with no special treatment for the beverage format. Interstate commerce prohibition forces manufacturers to establish operations in each state market. A beverage brand operating in California, Colorado, and Michigan must maintain three separate manufacturing facilities, obtain three sets of licenses, and source ingredients within each state. This requirement prevents economies of scale and increases costs compared to conventional beverage industries where manufacturers produce in one location and distribute nationally.

State-by-State Breakdown

California

California represents the largest cannabis beverage market with $180 million in sales during 2025, operating under MAUCRSA regulations administered by the Department of Cannabis Control. Single-serve beverages cannot exceed 10mg THC. Multi-serve containers are limited to 100mg total with clear serving demarcations. Type N manufacturing licenses cost $1,000-96,000 annually based on gross revenue. All products require laboratory testing for potency, pesticides, heavy metals, and contaminants. Packaging must be child-resistant, opaque, and include warning labels. Major brands include Keef, Cann, Kiva, and Lagunitas Hi-Fi Hops. The state collected approximately $27 million in excise taxes from beverage sales in 2025.

Colorado

Colorado pioneered cannabis beverage regulations following Amendment 64 passage in 2012. The Marijuana Enforcement Division limits single-serve beverages to 10mg THC and multi-serve products to 100mg with serving marks. Manufacturing licenses cost $2,500 annually. Testing requirements cover potency, pesticides, heavy metals, residual solvents, and microbial contaminants. Beverages generated approximately $62 million in retail sales during 2025. The state collected $45 million in combined excise and sales taxes from the beverage category. Colorado allows on-premise consumption in licensed tasting rooms, creating unique marketing opportunities.

Illinois

Illinois legalized adult-use cannabis through the Cannabis Regulation and Tax Act effective January 2020. The Department of Financial and Professional Regulation limits beverages to 10mg THC per serving. Infuser licenses cost $30,000 for application plus $200,000 if approved. The state requires social equity applicants receive priority licensing. Testing mandates cover potency, pesticides, heavy metals, and microbial contaminants. Illinois imposes a 10% cannabis excise tax on beverages plus 6.25% state sales tax. Beverage sales reached approximately $35 million in 2025. Major operators include Cresco Labs, Green Thumb Industries, and Verano Holdings.

Michigan

Michigan's Regulation and Taxation of Marihuana Act, approved by voters in 2018, created the regulatory framework for adult-use cannabis. The Cannabis Regulatory Agency limits single-serve beverages to 10mg THC. Processor licenses cost $40,000 for application and $25,000 annual renewal. All products require testing for potency, pesticides, heavy metals, mycotoxins, and microbial contaminants. Michigan allows microbusinesses to vertically integrate cultivation, processing, and retail, enabling smaller beverage producers. The state recorded approximately $48 million in beverage sales during 2025. The 10% excise tax generated roughly $4.8 million from beverages.

Nevada

Nevada legalized recreational cannabis through Question 2 in 2016, with sales beginning July 2017. The Cannabis Compliance Board limits beverages to 10mg THC per serving and 100mg per package. Production facility licenses cost $30,000 for application. Testing requirements include potency, pesticides, heavy metals, residual solvents, and microbial contaminants. Nevada's tourism-driven market creates unique opportunities for beverage sales to visitors. Las Vegas dispensaries report beverages comprising 4-6% of total sales. The state recorded approximately $41 million in beverage sales during 2025. The 15% wholesale excise tax plus 10% retail excise tax generated roughly $10 million from beverages.

Massachusetts

Massachusetts voters approved Question 4 in 2016, establishing adult-use cannabis regulations. The Cannabis Control Commission limits beverages to 5mg THC per serving—the lowest cap among major markets. Multi-serve containers cannot exceed 100mg total. Manufacturing licenses cost $1,500 for application. Testing covers potency, pesticides, heavy metals, mycotoxins, and microbial contaminants. The state requires opaque, child-resistant packaging with extensive warning labels. Massachusetts recorded approximately $28 million in beverage sales during 2025. The 10.75% excise tax plus 6.25% sales tax generated roughly $4.8 million from beverages.

Oregon

Oregon legalized recreational cannabis through Measure 91 in 2014. The Oregon Liquor and Cannabis Commission limits single-serve beverages to 10mg THC. Processor licenses cost $4,750 annually. Testing requirements include potency, pesticides, heavy metals, and microbial contaminants. Oregon prohibits beverages containing alcohol and cannabis in the same product. The state recorded approximately $22 million in beverage sales during 2025. The 17% retail sales tax generated roughly $3.7 million from beverages. Oregon allows delivery services, expanding beverage distribution options.

Washington

Washington's Initiative 502, approved in 2012, created one of the first adult-use markets. The Liquor and Cannabis Board limits beverages to 10mg THC per serving. Processor licenses cost $1,000 annually. Testing mandates cover potency, pesticides, heavy metals, and microbial contaminants. Washington requires beverages use child-resistant packaging and include warning labels. The state recorded approximately $31 million in beverage sales during 2025. The 37% excise tax plus sales tax generated roughly $13 million from beverages. Washington prohibits vertical integration, requiring separate licenses for production and retail.

Market and Business Implications

Cannabis beverages represent a $520 million U.S. market in 2025 with projected growth to $2.8 billion by 2027, driven by consumer preference for smoke-free consumption and faster onset times compared to traditional edibles. Wholesale economics favor beverages over many cannabis categories. Manufacturers sell THC beverages to dispensaries at $4-7 per unit depending on dosage and branding. Retail prices range from $8-15 per can, creating 40-50% gross margins for dispensaries—comparable to flower but higher than pre-rolls. Production costs for nanoemulsion beverages run $1.50-3.00 per unit including ingredients, packaging, testing, and labor. Established brands achieve contribution margins of 50-60% at wholesale prices. Capital requirements create barriers to entry. A commercial cannabis beverage facility requires $500,000-2 million in initial investment covering real estate, production equipment, quality control systems, and working capital. Nanoemulsion equipment costs $100,000-300,000 depending on capacity. Each state market requires separate facilities due to interstate commerce prohibition, multiplying capital needs for multi-state expansion. This capital intensity favors well-funded MSOs and partnerships with established beverage companies. Multi-state operators increasingly view beverages as strategic priorities. Cresco Labs reported beverage sales grew 180% year-over-year in 2024 following the FloraCal Farms line launch in California. Curaleaf's Select-branded THC seltzers achieved distribution in 400+ dispensaries across five states within 12 months of launch. Green Thumb Industries allocated $8 million to beverage production capacity expansion in 2025. Verano Holdings' Encore beverage line reached $12 million in annual revenue within 18 months. Alcohol industry involvement signals long-term confidence despite federal prohibition. Constellation Brands' $4 billion Canopy Growth investment represents the largest cannabis industry transaction by a Fortune 500 company. Molson Coors' Truss Beverage joint venture operates manufacturing facilities and distribution networks ready to scale if federal reform occurs. These partnerships provide cannabis companies with beverage formulation expertise, supply chain infrastructure, and retail relationships that would take years to develop independently. Consumer substitution patterns drive investment theses. Nielsen survey data from 2024 found 27% of legal-state cannabis consumers reduced alcohol consumption after trying THC beverages. Headset analytics reported 18% of cannabis beverage purchasers were first-time dispensary customers, suggesting the category attracts consumers who avoid smoking. Average basket size for beverage purchases ($47) exceeds the overall dispensary average ($38), indicating customers often buy beverages alongside other products. Technology licensing creates alternative business models. Vertosa's white-label nanoemulsion platform generated $18 million in revenue during 2024 by supplying emulsion technology to 50+ brands. This business-to-business model avoids retail competition while capturing value from the technology layer. Licensing fees typically run 8-12% of wholesale revenue plus upfront technology access fees of $50,000-150,000. Distribution challenges limit market penetration. Cannabis beverages require refrigeration, creating cold-chain logistics costs and limiting shelf space in dispensaries. Many dispensaries allocate only 2-4 linear feet to refrigerated beverages compared to 20-40 feet for flower displays. Delivery services and direct-to-consumer models remain restricted in most states, preventing the convenience-driven purchasing that drives conventional beverage sales. Pricing dynamics reflect premium positioning. THC beverages retail at $0.80-1.50 per milligram of THC compared to $0.10-0.30 per milligram for flower and $0.20-0.50 per milligram for edibles. Consumers pay this premium for faster onset, precise dosing, and social consumption formats. Price compression threatens margins as competition increases—California beverage prices declined 15% from 2023 to 2025 as new brands entered the market. Section 280E of the Internal Revenue Code prevents cannabis businesses from deducting ordinary business expenses, creating effective tax rates of 60-75%. Beverage manufacturers cannot deduct marketing costs, administrative salaries, or rent—only cost of goods sold. This tax treatment makes profitability challenging even for well-run operations. A beverage company with $10 million revenue and $6 million in operating expenses might face $2.4 million in federal taxes on $4 million gross profit, leaving minimal net income.

What Experts Say

Industry analysts and operators emphasize technology improvements and mainstream partnerships as key drivers while acknowledging regulatory uncertainty as the primary growth constraint. Bethany Gomez, managing director at Brightfield Group, stated in a March 2026 industry presentation that cannabis beverages would reach 8% of total edibles sales by 2027, up from 3% in 2023. According to Gomez, nanoemulsion technology improvements and celebrity-backed brands drive consumer trial while alcohol substitution creates sustained repeat purchase behavior among consumers aged 25-40. Brady Cobb, CEO of Sunburn Cannabis and newly appointed leader of Splash Beverage Group's cannabinoid strategy, said in a May 2026 statement that cannabis beverages represent "the most compelling growth opportunity in the regulated wellness sector." Cobb emphasized that beverage formats align with consumer preferences for dosing control and social consumption while offering higher margins than traditional cannabis categories. Keith Villa, founder of Ceria Brewing and former Blue Moon creator, explained in a 2025 interview with Beverage Industry magazine that cannabis beverages face a "education and trial barrier" where consumers unfamiliar with THC effects hesitate to purchase. According to Villa, brands succeed by emphasizing low-dose formats (2-5mg THC) that allow gradual titration and by positioning products as alcohol alternatives rather than cannabis products. Troy Datcher, CEO of The Parent Company (which operates Caliva and Mirayo brands), stated in a fourth-quarter 2025 earnings call that beverages comprised 7% of company revenue despite representing only 3% of dispensary shelf space. Datcher noted that beverage consumers show higher lifetime value and purchase frequency compared to flower-only customers, making the category strategically important despite lower absolute sales volumes. Nancy Whiteman, CEO of Wana Brands, said in a 2024 Cannabis Business Times interview that fast-acting beverages using nanoemulsion technology "fundamentally change the value proposition" by delivering effects comparable to alcohol in timing. According to Whiteman, onset times under 20 minutes enable social consumption patterns impossible with traditional edibles requiring 60-90 minutes to take effect. David Culver, vice president of government relations at Canopy Growth, stated in congressional testimony in March 2025 that federal prohibition prevents cannabis beverage companies from accessing banking services, trademark protection, and interstate commerce—creating competitive disadvantages versus alcohol that cost the industry an estimated $400 million annually in duplicative infrastructure and compliance costs. Dr. Ethan Russo, neurologist and cannabis researcher, explained in a 2024 Journal of Cannabis Research article that water-soluble cannabinoid formulations achieve higher bioavailability through enhanced absorption in the gastrointestinal tract. According to Russo's research, nanoemulsion beverages deliver 70-90% of consumed cannabinoids to systemic circulation compared to 10-20% for traditional edibles, enabling lower doses and more predictable effects.

What's Next

Cannabis beverage market evolution depends on three key developments: federal rescheduling decisions, alcohol industry consolidation, and technology standardization. The Drug Enforcement Administration's ongoing review of marijuana's Schedule I classification represents the most significant near-term catalyst. If the DEA reschedules cannabis to Schedule III as recommended by the Department of Health and Human Services in August 2023, cannabis businesses would gain access to normal tax treatment under Section 280E, potentially improving beverage manufacturer profitability by 20-30%. Rescheduling would not legalize interstate commerce or end state-level prohibition, but would reduce federal enforcement risks and enable banking access. The DEA's final decision timeline remains uncertain as of May 2026, with administrative law judge hearings scheduled through late 2026. Congressional legislation offers a more comprehensive solution. The Cannabis Administration and Opportunity Act, reintroduced in the Senate in 2025, would deschedule cannabis entirely and establish federal regulatory frameworks. The bill includes provisions for interstate commerce, trademark protection, and FDA oversight of cannabis beverages similar to alcohol regulation. Senate passage remains unlikely given Republican opposition, but the bill's reintroduction signals continued Democratic support for comprehensive reform. State-level expansion continues regardless of federal action. Ohio launched adult-use sales in January 2026 following Issue 2 passage in November 2023. Pennsylvania, Minnesota, and Delaware have active legalization efforts with potential implementation in 2027-2028. Each new state market represents $15-40 million in potential annual beverage sales based on population and existing medical market size. Florida's Amendment 3, if approved by voters in November 2026, would create a market potentially exceeding $100 million in annual beverage sales given the state's 22 million residents and tourism industry. Technology development focuses on improving stability and reducing costs. Current nanoemulsion formulations require specialized equipment and expertise, limiting production to established manufacturers. Emerging technologies including microencapsulation and cyclodextrin complexation promise simpler production processes and longer shelf